1 glule par jour avec un verre deau, de prfrence pendant 3 mois
For example, the nonprofit Institute for Safe Medication Practices published a white paper on wellness peptides earlier this year, drawing attention to the gaps in evidence and warning that much of the data comes from preclinical studies done in animals, not humans
[DOI] [PubMed] [Google Scholar] Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, et al
New preliminary Noom data show that members who used Nooms GLP-1 programs maintained the vast majority of their weight loss after stopping medication, with modeled estimates showing less than 2% body weight regain up to 12 months after discontinuation
These results provide context for personalizing treatmentnot predictions of exact medication responseenabling your provider to make informed decisions about starting doses, titration pacing, and whether dual-peptide approaches may offer additional benefit